The extracellular matrix may induce detrimental inflammatory responses on degradation, causing adverse cardiac remodeling and heart failure. The extracellular matrix protein fibronectin-EDA (EIIIA; EDA) is upregulated after tissue injury and may act as a "danger signal" for leukocytes to cause adverse cardiac remodeling after infarction.
H eart failure (HF) is becoming a major socioeconomic burden for Western societies, because both incidence and prevalence numbers are increasing. 1 Improved reperfusion strategies have caused a decline in death rates after acute myocardial infarction (MI). However, because more patients do survive the initial infarction, infarct-related morbidity increases. The extent of tissue loss in the acute phase after MI is a major determinant of the degree of adverse remodeling. However, chronic processes like extracellular matrix (ECM) turnover, fibrosis, and inflammation are key mediators of post-MI cardiac repair and adverse remodeling. 2 Despite pharmacological advances (eg, ␤-blockers, renin-angiotensin-aldosterone system inhibitors), 3, 4 incidence for HF is increasing and mortality remains very high (5- year mortality, 30% to 70%). 5 Inflammation is the first critical step in tissue repair responses after MI. Many interventions have been studied to modulate the inflammatory reaction to enhance heart function and attenuate structural changes leading to HF. However, interfering within the innate immune system is not without danger and necessitates understanding the temporal, spatial, and (patho)physiological role of the target. 2, 6 Endogenous "danger signals" have gained much interest recently, because they are released after tissue injury and do not play a biological role under normal conditions. Danger signals (eg, cardiac myosin 7 and HMGB1 8 ) are released on ECM degradation or cardiomyocyte death and can activate leukocytes, thereby inducing the detrimental responses seen after MI. Toll-like receptors (TLRs) are postulated as one of the main targets for endogenous ligands released after infarction. 9 On recognition of endogenous ligands, TLRs exert the same detrimental inflammatory processes via cytokine and chemokine expression.
Cellular fibronectin is a multifunctional adhesive glycoprotein present in the ECM and is produced by cells (eg, fibroblast, endothelial cells) in response to tissue injury. It contains an alternatively spliced exon encoding type III repeat extra domain A (EIIIA; EDA) that act as an endogenous ligand for both TLR2 and -4; in vitro, EDA induces proinflammatory gene expression and activates monocytes. 10 Furthermore, in vivo injection of EDA in murine joints results in enhanced inflammation via nuclear factor B activation. 11 In addition to its proinflammatory actions, EDA also acts as a ligand for several integrins (eg, VLA-4/CD49d) regulating cell adhesion and proliferation. 12, 13 The presence of EDA is also crucial for myofibroblast phenotype induction and function. 14 In summary, EDA is able to activate leukocytes and cause an upregulation of cytokines and chemokines. One might hypothesize that on degradation of the ECM and/or de novo synthesis after infarction, EDA could cause detrimental inflammatory responses. In the present study, we show, in vivo, that the lack of EDA indeed prevents adverse cardiac remodeling and enhances cardiac function after acute MI.
Methods

Animals and Experimental Design
EDA Ϫ/Ϫ mice were kindly provided by Dr John H. Peters and back-crossed into a Balb/C background for 8 generations. Male Balb/C wild-type (WT), EDA Ϫ/Ϫ , and chimeric mice (10 to 12 weeks, 25 to 30 g) received standard diet and water ad libitum. Myocardial infarction was induced by left coronary artery ligation, just below the left atrial appendage. All animal experiments were performed in accordance with the national guidelines on animal care and with prior approval by the Animal Experimentation Committee of Utrecht University.
Online Data Supplement
An expanded Methods section is available in the Online Data Supplement at http://circres.ahajournals.org and contains detailed information regarding MI in vivo, protein and RNA isolation, flow cytometry, the generation of chimeric mice, infarct size calculation, MRI measurements, invasive left ventricular (LV) pressure measurements, immunohistochemistry, polymerase chain reaction, zymography, caspase 3/7 activity, elastase activity, myofibroblast culture, fibronectin-EDA Western blotting, and statistical analysis.
Results
Lack of EDA Promotes Survival and Prevents Heart Function Deterioration, As Well As Maladaptive Remodeling, After Myocardial Infarction
EDA synthesis is stimulated after infarction in both infarct and remote myocardium, reaching a peak at 7 and 3 days, respectively (Online Figure I) . Baseline MRI assessment of cardiac function and dimensions revealed no differences between EDA Ϫ/Ϫ and WT mice. Microscopic analyses did not show any alterations in cellularity and matrix composition in EDA Ϫ/Ϫ mice (Online Figure II) .
The extent of endangered myocardium (area at risk/LV) determined at 2 days after MI was similar between the groups. Infarct size as percentage of LV was also similar between groups (infarct size/LV 38.2Ϯ1.2%, Pϭ0.985; Figure 1A ). Kaplan-Meier survival analysis showed a significant survival benefit in EDA Ϫ/Ϫ mice over WTs ( Figure 1B ). Most deaths occurred after day 6 and were not caused by cardiac rupture (only 2 ruptures in the WT and 1 rupture in EDA Ϫ/Ϫ mice were observed during 28 days follow-up). In line with increased mortality, WT mice had greater LV dimensions and reduced systolic performance compared with EDA Ϫ/Ϫ mice ( Figure 1C ; Table 1 ). These significant differences were already present 7 days after infarction, and continued to deteriorate till 28 days after MI. EDA Ϫ/Ϫ mice were relatively protected against remodeling and exhibited better systolic function after MI ( Figure 1C ; Table 1 ). The protective effect seen in EDA Ϫ/Ϫ was not attributable to changes in the extent of viable tissue, because infarct size did not differ between WT and EDA Ϫ/Ϫ mice 28 days after MI (33.7Ϯ2.3% versus 34.3Ϯ3.5%, respectively; Pϭ0.818). However, wall thickness of the infarct area did not decline in EDA Ϫ/Ϫ mice as much as in WTs. At day 28 postinfarction, the entire infarct area was replaced by a dense collagen network in both groups. At day 7, however, there was reduced granulation of the infarct as shown by delayed degradation of acellular matrix in EDA Ϫ/Ϫ mice ( Figure 1D ). 
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Lack of EDA Decreases Endogenous MMP-2, -9, and Elastase Activities
Enhanced MMP2 and -9 activities are detrimental for cardiac performance and geometry during the postinfarct healing process. We performed zymography to study whether the protection against adverse remodeling seen in EDA Ϫ/Ϫ mice is also attributable to changes in proteinase activity. In line with the reduced matrix degradation in the knock-out animals at day 7 observed in histology, both active forms of MMP-2 and -9 in infarct areas were reduced in EDA Ϫ/Ϫ mice, 7 days postinfarction ( Figure 2 ). Analysis of the remote area after 7 days infarction was not possible because of very low signal intensity. Finally, we studied whether elastase activity was also affected by the absence of EDA. In line with reduced MMP2 and -9 activity, elastase activity was also reduced in EDA Ϫ/Ϫ mice 7 days after infarction (Online Figure III ).
EDA ؊/؊ Mice Exhibit Less Postinfarct Fibrosis
Collagen deposition occurs in the infarct area on degradation of the matrix and in the remote myocardium on changes in wall stress. Myofibroblasts are the primary source of de novo collagen synthesis. 2 In our study, collagen deposition in both the infarct and remote area was similar between the groups at day 7 after MI (Online Figure IV ). After 28 days, collagen content was again similar in the infarct area, suggesting that scar formation is not negatively affected in EDA Ϫ/Ϫ mice ( Figure 3A ). However, the remote myocardium now contained less collagen fibers in EDA Ϫ/Ϫ mice compared with WT animals ( Figure 3B ; lower pixel count in the small-size gray value spectrum). These findings were supported at the mRNA level. Both procollagen-1 and -3 are reduced in the remote myocardium of EDA Ϫ/Ϫ mice ( Figure 3C ). Within the infarct, collagen synthesis in EDA Ϫ/Ϫ mice was again comparable to WT animals. There was no difference in lysyl-oxidase and TIMP-2 production between the groups, suggesting no differences in collagen cross-linking and protease inhibition, respectively (Online Figures V and VI). The reduced fibrosis in the remote myocardium at 28 days after MI is preceded by a significantly decreased myofibroblast transdifferentiation in EDA Ϫ/Ϫ mice, in both remote and infarct areas 7 days after infarction ( Figure 3D and 3E). Periostin is described as a maturation factor of cardiac fibroblasts. 15 In our study, periostinpositive area was reduced as well in EDA Ϫ/Ϫ mice compared with WT animals ( Figure 3F ; Online Figure  VII ). To study whether WT and EDA Ϫ/Ϫ myofibroblasts differed in their matrix synthesis activity and MMP expression profile, we cultured postinfarct myofibroblasts and stained for myofibroblast markers and procollagen III. In vitro, There were no differences between the 2 genotypes (Online Figure VIII ). In addition, zymography was done using the supernatants of the cells and showed also no differences in MMP2 and -9 activity (Online Figure IX ).
Lack of EDA Results in Enhanced Inotropy and Lusitropy
Altered fibrotic processes in EDA Ϫ/Ϫ mice indicate that diastolic function could be affected as well. Table 2 shows the results from the invasive LV pressure assessments. Contractility, as indicated by dP/dT max , was much higher in EDA Ϫ/Ϫ mice after 28 days infarction. This confirmed our previous MRI findings, that EDA Ϫ/Ϫ mice exhibit enhanced systolic performance ( Table 1) . Increase of LV end-diastolic pressure and tau is detrimental for heart function and is caused by increase of EDV and/or fibrosis, one of the hallmarks of heart failure. Compared with WT animals, diastolic performance 
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was also significantly enhanced in EDA Ϫ/Ϫ mice after 28 days infarction. Both parameters were significantly lower in EDA Ϫ/Ϫ mice compared with WT animals, providing evidence that the improved survival in EDA Ϫ/Ϫ mice is a consequence of both systolic and diastolic functional improvements.
EDA Regulates Post-MI Inflammation
Lack of EDA should result in a decreased inflammatory status, because EDA is considered as a ligand for TLR2 and -4. Neutrophils are the first leukocyte subset migrating on tissue injury and are known to be associated with the extent of damage. Neutrophil count in the infarct area was not different between the groups ( Figure 4A ). Hereafter, macrophages clear cell debris (eg, necrotic neutrophils and cardiomyocytes) and, more importantly, initiate the remodeling process after infarction. 2 In our study, the number of macrophages was highly reduced in EDA Ϫ/Ϫ mice 7 days postinfarction ( Figure 4B ). There were no cells detectable after 28 days infarction in both groups (data not shown). In concordance with the reduced macrophage influx, levels of tumor necrosis factor (TNF)␣, RANTES, granulocyte/macrophage colony-stimulating factor (GM-CSF) (responsible for recruitment, differentiation and maturation of macrophages) and interleukin-10 were highly reduced in EDA Ϫ/Ϫ mice, 7 days after infarction ( Figure 4C through 4F) . In contrast, monocyte chemoattractant protein (MCP)-1 levels were increased in EDA Ϫ/Ϫ mice compared with WT animals at protein and mRNA level (Online Figure X) .
Parenchymal EDA Mediates Postinfarct Survival and Maladaptive Remodeling
We generated chimeric mice to differentiate between the contribution of the blood and parenchymal compartments to the observed effects after MI. Interestingly, WT/EDA KO BM had similar survival rates and cardiac performance compared with WT/WT BM animals. In contrast, EDA KO/WT BM were similar to EDA KO/EDA KO BM animals and showed higher survival rates and exhibited less adverse remodeling after MI, compared with WT/EDA KO BM ( Figure 5A and 5B; Table 1 ). These data indicate that postinfarct parenchymal EDA expression drives maladaptive remodeling. From a danger model perspective, we may postulate that EDA expression as a danger signal can have profound effects on circulating cells which are responsible for postinfarct repair responses.
EDA Mediates Both Integrin-␣4 and Toll-Like Receptor Signaling in Circulating Monocytes
EDA is a known ligand for integrin-␣4␤1 (VLA-4) 12 and TLR2 and -4. 10 Because parenchymal EDA mediates adverse remodeling, we hypothesized that EDA from the heart may serve as an endogenous activator of circulating cells after infarction. EDA Ϫ/Ϫ mice showed a significant reduction in peripheral monocytes 3 days after infarction, whereas after 7 days the numbers were similar between the groups ( Figure  6A ). TLR2 expression on monocytes was significantly altered in the absence of EDA, whereas TLR4 did not show any difference in expression levels after MI between the groups (Figure 6B and 6C ). Integrin-␣4 (CD49d) expression was also significantly reduced on monocytes of EDA Ϫ/Ϫ mice after infarction ( Figure 6D ). In addition, there was a subgroup of monocytes that showed a significant higher expression level of CD49d. EDA Ϫ/Ϫ mice showed again a reduced CD49d expression in this subgroup, 7 days postinfarction ( Figure 6E ).
Discussion
HF is already considered as an epidemic of the 21st century and its socioeconomic burden of HF is likely to increase. 16 Mortality after acute MI declines because of 
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Fibronectin-EDA Absence in Post-MI Remodeling pharmacological and technical advances facilitating early reperfusion and survival. However, morbidity increases because of the excessive tissue loss and detrimental chronic processes during infarct healing. Inflammation is necessary for adequate wound healing and interfering with antiinflammatory agents may be devastating. 17 However, postinfarct recovery is characterized by an autodestructive inflammatory response causing a vicious circle. Hereby, the same inflammatory response influences cardiac performance and geometry in a detrimental way. This adverse healing process causes changes in ventricular structural design and dimension, referred as adverse cardiac remodeling. Despite the therapeutic advances for patients experiencing acute MI, there is a window of opportunity for adjunctive interventions. In particular, therapeutic targets within our innate immune system hold great promise for future application for cardiomyocyte salvage after acute MI. 18, 19 Ideally, the optimal therapy for patients experiencing acute MI encompasses both cardiomyocyte salvage and attenuating adverse remodeling, without affecting a proper scar formation. The discovery of TLRs has not only provided us with great insight into pathophysiological mechanisms in HF but may also hold therapeutic value. We and others have shown that deficient TLR2 and -4 activation has therapeutic effects in murine models of atherosclerosis 10, 20 and cardiac ischemia. 19, [21] [22] [23] The idea that pattern-recognition receptors also induce detrimental inflammatory responses in noninfectious settings has resulted in the search for endogenous ligands, so called danger signals. These danger signals are thought to be released and/or produced during tissue injury and cell stress. From this "danger model" perspective, 24 EDA may be a critical mediator of adverse remodeling after MI.
We have shown that EDA is indeed upregulated after acute MI. This is in line with previous reports that EDA is produced in response to tissue injury (reviewed in Ref. 12 ). EDA mRNA levels peaked at day 7 after MI in the infarcted wall and returned to baseline levels after 28 days. Immunohistochemistry suggested similar if not greater expression of EDA in the remote myocardium. The discrepancy between mRNA and protein levels and EDA staining could potentially reflect sampling of EDA pools of differing solubility. Experiments with cultured cells have shown that, after synthesis and secretion, soluble fibronectin dimers first appear at the cell surface but, over time, incorporate into less soluble multimeric aggregates in the ECM. 25 Immunohistologic analysis has the capacity to detect such insoluble fibronectin aggregates in the ECM of tissues, whereas immunoblot analysis is apt to preferentially detect soluble extractable fibronectins. 25 Potentially, EDA that is produced after the modest increase in EDA transcription in remote myocardium could preferentially incorporate into an insoluble fibronectin pool, thereby becoming relatively more evident by immunohistologic than immunoblot analysis (Online Figure I) . Despite similar infarct size, EDA Ϫ/Ϫ mice showed enhanced survival compared with WT animals. In addition, WT animals exhibited a severely affected cardiac function and profound expansive remodeling during 28 days of recovery. In contrast, EDA Ϫ/Ϫ mice showed preserved LV geometry, better systolic performance and less LV bulging during systole. Interestingly, this protective effect was already significant 7 days after infarction and continued to be apparent in the long-term follow-up. The detrimental changes were associated with the EDA mRNA peak seen at day 7.
We explored several cellular and molecular mechanisms to explain the protective effect of EDA absence after MI.
First, we showed that EDA Ϫ/Ϫ mice have a normal scar formation (normal collagen content in infarct area), whereas remote fibrosis was decreased. This was also supported at the mRNA level for both procollagen-1 and -3, showing only decreased expression in the remote area. Furthermore, granulation of the infarct area was delayed and wall thickness did not decline in EDA Ϫ/Ϫ mice as much as in WT animals. In addition, myofibroblast transdifferentiation in the postinfarct ventricular wall was highly suppressed in EDA Ϫ/Ϫ mice. These observations suggest that EDA does not mediate fibrosis directly, because there is selective attenuation of fibrosis in the remote myocardium and not in the scar area in EDA Ϫ/Ϫ mice. We may hypothesize the following mechanisms: because of delayed matrix degradation in EDA Ϫ/Ϫ after infarction, infarct thinning is also delayed. The thicker wall of the infarct area in EDA Ϫ/Ϫ mice results in less wall stress and thus end-diastolic volume is limited. In addition, the decreased wall stress in EDA Ϫ/Ϫ mice may explain the decreased LV pressure overload in these mice. Subsequently, reduced ventricular pressure may result in reduced fibrosis of the remote myocardium, as observed in our EDA Ϫ/Ϫ animals 28 days after infarction. Invasive pressure measurements indeed revealed that WT animals have nearly 90% increase of both LV end-diastolic pressure and LV relaxation time compared with EDA Ϫ/Ϫ mice. We studied whether apoptosis in the remote myocardium could explain the functional impairment in WT animals, but did not observe a difference in caspase 3 and 7 activity between the groups during follow-up (Online Figure  XI) .
Secondly, we studied the inflammatory status in the postinfarct hearts. The absence of EDA did not affect neutrophil count, suggesting that the extent of tissue injury was similar between the groups. This is supported by the observation that infarct size did not differ between the groups. In contrast, macrophages (known as key players in adverse cardiac remodeling) migrated less in both the infarct and remote myocardium of EDA Ϫ/Ϫ mice. In addition, lack of EDA protected the animals against the production of TNF␣, RANTES, and GM-CSF: all known detrimental (chemotactic) cytokines in acute MI and HF, negatively affecting cardiomyocyte survival and function and ECM remodeling. 2, 18 In contrast, MCP-1 is increased in EDA Ϫ/Ϫ mice. There are several possible explanations for reduced migration of mononuclear cells in EDA Ϫ/Ϫ mice despite increased MCP-1 levels. First, decreased CD49d expression seen in our experiments results in reduced migration capacity of monocytes ( Figure 6 ). 26 It is likely that MCP-1 fails to cause effective migration because of reduced CD49d expression on monocytes. The complexity of the role of MCP-1 in adverse remodeling is also shown by the fact that several studies have reported contradictory results. Both cardiac-specific MCP-1 over- 
Fibronectin-EDA Absence in Post-MI Remodeling expression and MCP-1 inhibition have shown to prevent adverse remodeling and fibrosis after infarction. [27] [28] [29] Thirdly, we studied MMP and elastase secretion because MMP2, -9 and elastase have been described as mediators of adverse cardiac remodeling. 30 Both endogenous MMP2, -9 and elastase activities were decreased in EDA Ϫ/Ϫ mice compared with WT animals. These findings corroborate our MRI observations, in which wall thickness of the infarcted free wall is thicker in EDA Ϫ/Ϫ mice, already at 7 days after MI (Table 1 ). Our observation of decreased endogenous MMP2 and -9 activities in the absence of EDA is supported by Okamura Y et al They showed that EDA mediates MMP9 production via TLR4 activation. 31 Despite the fact that they did not see any effect on MMP2 production in vitro, we did show that MMP2 was affected as well in vivo. One possible explanation is that the in vitro setting used by Okamura Y et al does not represent the spatial and temporal dependence of MMP production; infarct and remote myocardium have their own MMP signature during the post-MI period. 30 In addition, we examined whether EDA is a direct inhibitor of MMP2 and -9. Adding recombinant EDA to MMP2 and -9 did not have an inhibitory effect (Online Figure XII) , suggesting that the reduced MMP2 and -9 activity observed in vivo is likely via reduced secretion.
Finally, we found that EDA expression in resident myocardial cells mediate LV remodeling after infarction. Moreover, we have shown that circulating monocytes are significantly affected in the absence of EDA. Besides the fact that monocyte numbers are temporarily decreased after infarction, the absence of EDA also downregulates TLR2 and CD49d expression in vivo.
Taking these novel findings into account, we can hypothesize the following on the mode of action of EDA: (1) both leukocytes and cardiac fibroblasts, critically involved in cardiac remodeling, are activated by the danger signal EDA produced in the heart after MI; and (2) leukocytic integrins (eg, ␣4␤1) have higher binding affinity to the ECM in the presence of EDA, 32 resulting in increased migration and/or differentiation of leukocytes after MI. It is very likely that both fibroblast transdifferentiation and leukocytic activation and migration contribute equally to the observed effects in our study. Table 1 ) compared with WT/EDA Ϫ/Ϫ BM ischemic mice. Each bar represents meansϮSEM (nϭ11/group). WT/WT BM indicates WT with WT bone marrow; EDA KO/EDA KO BM, EDA Ϫ/Ϫ mice with EDA Ϫ/Ϫ bone marrow; WT/EDA KO BM, WT mice with EDA Ϫ/Ϫ bone marrow; EDA KO/WT BM, EDA Ϫ/Ϫ animals with WT bone marrow.
In summary, we have shown that EDA is upregulated in response to the infarction and returns to normal levels after long-term survival. In the absence of EDA, postinfarct adverse remodeling is highly attenuated with concomitant survival benefit. EDA Ϫ/Ϫ mice are relatively protected against the profound expansive remodeling. In addition, both systolic and diastolic performance is preserved in EDA Ϫ/Ϫ mice via decreased fibrosis and altered inflammation. 
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Novelty and Significance
What Is Known?
• Myocardial infarction (MI) initiates a repair response characterized by inflammation and tissue remodeling. • Toll-like receptor (TLR) activation enhances inflammation and deteriorates cardiac function and geometry after MI. • Extracellular matrix (ECM) components are known to activate circulating blood cells that migrate into injured tissue via TLRs and integrins. • Fibronectin-EDA is an ECM protein upregulated after tissue injury that can activate monocytes and fibroblasts.
What New Information Does This Article Contribute?
• Fibronectin-EDA is a critical mediator of cardiac remodeling and subsequent survival after MI in mice. • Fibronectin-EDA-deficient mice with wild-type bone marrow exhibited reduced left ventricular dilatation and fibrosis, without affecting proper scar formation after MI. • In the absence of fibronectin-EDA, leukocyte influx and cytokine production was reduced, as well as myofibroblast transdifferentiation and activation after MI.
• Fibronectin-EDA deficiency reduced peripheral monocyte mobilization and reduced monocytic TLR2 and CD49d expression in the blood after MI Inflammation is a critical first step in cardiac remodeling after MI. The extent and type of inflammation determines whether tissue remodeling becomes adaptive or maladaptive. Adverse cardiac remodeling results in loss of structural design and integrity of the infarcted, as well as the remote myocardium, eventually causing left ventricular dilatation and heart failure. ECM proteins and degradation products are postulated as danger signals that initiate innate immune responses after tissue injury. The present study demonstrates that fibronectin-EDA is a critical mediator of cardiac remodeling after MI. Lack of fibronectin-EDA prevents left ventricular dilatation and promoted survival after experimental MI in mice. In the absence of fibronectin-EDA, postinfarct inflammation and fibrosis were reduced; tissue degradation was decreased, but scar formation was not affected. Our study indicates that fibronectin-EDA links tissue injury to inflammation after MI.
